Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Joshua

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 30, 2015
Choosing a better end point for trials of bone-protective agentsR Leibowitz-Amit, L Khoja, I F Tannock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2005
Small blue cell tumors of the rectum. Case 2. Small-cell carcinoma of the rectumA M Joshua, D Adams, P McKenzie, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 2022
Clinical trials for metastatic castrate-resistant prostate cancer-who is looking after the control patients? Questions for the futureL C Ardolino, R Dear, A J Armstrong, et al.
Internal Medicine Journal|September 24, 2005
Weekly docetaxel as second line treatment after mitozantrone for androgen-independent prostate cancerA M Joshua, I Nordman, R Venkataswaran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2005
Small blue cell tumors of the rectum. Case 1. Ewing's sarcoma of the rectumJ Vardy, A M Joshua, S J Clarke, et al.
Current Oncology (Toronto, Ont.)|January 5, 2017
Burden of illness for metastatic melanoma in Canada, 2011-2013D S Ernst, T Petrella, A M Joshua, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 24, 2015
Treatment of mCRPC in the AR-axis-targeted therapy-resistant stateK Chi, S J Hotte, A M Joshua, et al.
Endocrine Oncology (Bristol, England)|September 12, 2025
Efficacy of systemic therapy in metastatic adrenocortical carcinoma: a meta-analysis of prospective clinical trialsS Shekar, A Hall, J Pham, et al.
Cancer Chemotherapy and Pharmacology|April 6, 2017
Up-regulation of autophagy is a mechanism of resistance to chemotherapy and can be inhibited by pantoprazole to increase drug sensitivityQian Tan, A M Joshua, M Wang, et al.
Biochimica Et Biophysica Acta|January 2, 2008
Prostatic preneoplasia and beyondA M Joshua, A Evans, T Van der Kwast, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 30, 2015
Choosing a better end point for trials of bone-protective agentsR Leibowitz-Amit, L Khoja, I F Tannock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2005
Small blue cell tumors of the rectum. Case 2. Small-cell carcinoma of the rectumA M Joshua, D Adams, P McKenzie, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 2022
Clinical trials for metastatic castrate-resistant prostate cancer-who is looking after the control patients? Questions for the futureL C Ardolino, R Dear, A J Armstrong, et al.
Internal Medicine Journal|September 24, 2005
Weekly docetaxel as second line treatment after mitozantrone for androgen-independent prostate cancerA M Joshua, I Nordman, R Venkataswaran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2005
Small blue cell tumors of the rectum. Case 1. Ewing's sarcoma of the rectumJ Vardy, A M Joshua, S J Clarke, et al.
Current Oncology (Toronto, Ont.)|January 5, 2017
Burden of illness for metastatic melanoma in Canada, 2011-2013D S Ernst, T Petrella, A M Joshua, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 24, 2015
Treatment of mCRPC in the AR-axis-targeted therapy-resistant stateK Chi, S J Hotte, A M Joshua, et al.
Endocrine Oncology (Bristol, England)|September 12, 2025
Efficacy of systemic therapy in metastatic adrenocortical carcinoma: a meta-analysis of prospective clinical trialsS Shekar, A Hall, J Pham, et al.
Cancer Chemotherapy and Pharmacology|April 6, 2017
Up-regulation of autophagy is a mechanism of resistance to chemotherapy and can be inhibited by pantoprazole to increase drug sensitivityQian Tan, A M Joshua, M Wang, et al.
Biochimica Et Biophysica Acta|January 2, 2008
Prostatic preneoplasia and beyondA M Joshua, A Evans, T Van der Kwast, et al.
Pageof 4